{
    "2200": {
        "explanation_text": "Malignant neoplasm of urinary organ, unspecified.",
        "symptom_text": "The patient has a history of recurrent urinary tract infections and a family history of bladder cancer.The patient presented with painless hematuria and abdominal discomfort.CT scan revealed a mass in the urinary organ with no evidence of metastasis.Malignant neoplasm of urinary organ, unspecified. The urinary organ mass identified on CT scan, along with the symptom of painless hematuria, supports this diagnosis.The patient has no history of bladder or urethral neoplasms, and the CT findings are consistent with a primary malignancy in the urinary organ.The patient is scheduled for a transurethral resection of the tumor followed by chemotherapy.The patient tolerated the procedure well and was discharged home with a follow-up appointment in the oncology clinic next week.67MaleCaucasian"
    },
    "2201": {
        "explanation_text": "Malignant neoplasm of cerebral meninges.",
        "symptom_text": "The patient has a history of chronic headaches and episodes of confusion over the last few months, prompting further evaluation.The patient presents with persistent, severe headaches, occasional seizures, and progressive weakness in the right arm.MRI of the brain shows diffuse thickening and enhancement of the cerebral meninges, consistent with meningeal involvement.Malignant neoplasm of cerebral meninges (C700): The MRI findings reveal diffuse thickening and enhancement of the cerebral meninges, supporting the diagnosis of malignant neoplasm involving the meninges.The patient's symptoms of persistent headaches, seizures, and neurological deficits are concerning for a primary brain pathology, particularly involving the meninges. Further neurosurgical consultation is recommended.The patient is scheduled for a craniotomy for biopsy and further management. In the interim, symptomatic treatment with antiepileptic medications and analgesics is initiated.56FemaleCaucasian"
    },
    "2202": {
        "explanation_text": "Malignant neoplasm of frontal lobe.",
        "symptom_text": "The patient has a history of chronic headaches and recent episodes of confusion and memory loss.The patient presents with persistent headaches, cognitive decline, and personality changes.MRI shows a mass in the frontal lobe with surrounding edema.Malignant neoplasm of frontal lobe (C711): A primary malignant neoplasm arising from the frontal lobe of the brain.Neurological examination revealed signs of increased intracranial pressure and focal neurological deficits consistent with frontal lobe involvement.The patient underwent a craniotomy for tumor resection followed by radiation therapy.The patient was discharged in stable condition with close follow-up for ongoing management of the frontal lobe tumor.58MaleCaucasian"
    },
    "2203": {
        "explanation_text": "Malignant neoplasm of brain, unspecified.",
        "symptom_text": "The patient has no significant past medical history of malignancies or neurological disorders.The patient presented with persistent headaches, blurred vision, and episodes of seizures.MRI of the brain revealed a large mass in the right frontal lobe with surrounding edema.Malignant neoplasm of brain, unspecified (C719): The patient presents with a large mass in the right frontal lobe on MRI, consistent with a primary brain tumor.The patient's neurological examination showed signs of increased intracranial pressure, including papilledema and altered mental status.The patient underwent surgical resection of the brain tumor followed by adjuvant radiation therapy.The patient was discharged in stable condition with close follow-up for radiation therapy side effects and tumor recurrence monitoring.56FemaleCaucasian"
    },
    "2204": {
        "explanation_text": "Malignant neoplasm of thyroid gland.",
        "symptom_text": "The patient has a history of thyroid nodules and a family history of thyroid cancer.The patient presents with a painless neck mass, hoarseness, and difficulty swallowing.Ultrasound of the neck shows a solid nodule in the thyroid gland. Fine-needle aspiration biopsy confirms malignancy.Malignant neoplasm of thyroid glandPatient presents with classic symptoms of thyroid malignancy including a neck mass, hoarseness, and dysphagia. Diagnostic tests confirm the presence of a malignant thyroid nodule.The patient is scheduled for a total thyroidectomy followed by radioactive iodine therapy.The patient underwent successful total thyroidectomy without complications and is planned for radioactive iodine therapy as an outpatient.45FemaleCaucasian"
    },
    "2205": {
        "explanation_text": "Malignant neoplasm of head, face and neck.",
        "symptom_text": "The patient has a history of chronic sun exposure due to outdoor work.The patient presented with a painless lump on the right side of the neck that has been slowly increasing in size over the past few months.Biopsy results confirmed squamous cell carcinoma.Malignant neoplasm of head, face and neck: C760 - Malignant neoplasm of head, face, and neckUpon examination, a firm, non-tender mass was palpated on the right side of the neck, measuring approximately 3 cm in diameter. No other masses or lymphadenopathy were noted in the head, face, or neck region.The patient underwent surgical excision of the neck mass followed by radiation therapy. Regular follow-ups are scheduled for monitoring and further management.The patient was discharged in stable condition with appropriate wound care instructions and referrals for oncology follow-up.58 years oldMaleCaucasian"
    },
    "2206": {
        "explanation_text": "Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck.",
        "symptom_text": "The patient has a history of treated breast cancer with no evidence of recurrence. No history of primary brain or thyroid malignancy.The patient presented with painless enlarged lymph nodes in the head, face, and neck region for the past two months.CT scan revealed multiple enlarged lymph nodes in the head, face, and neck region. Biopsy confirmed metastatic involvement.Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck.Patient's physical examination showed multiple palpable lymph nodes in the head, face, and neck region. No other concerning findings noted.Initiated chemotherapy regimen tailored for metastatic lymphadenopathy. Referral made to oncology for further management.The patient tolerated treatment well with no significant adverse effects. Discharged with close follow-up for chemotherapy cycles.57FemaleCaucasian"
    },
    "2207": {
        "explanation_text": "Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes.",
        "symptom_text": "The patient has a history of colon cancer treated with surgery and chemotherapy.The patient presented with abdominal pain, unintentional weight loss, and fatigue.CT scan of the abdomen revealed enlarged intra-abdominal lymph nodes with no other organ involvement.Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes.The patient's symptoms and diagnostic tests are consistent with metastasis to the intra-abdominal lymph nodes from a previous colon cancer.The patient will undergo further imaging studies to assess the extent of metastasis and will be referred to an oncologist for treatment planning.The patient is stable and will follow up with the oncologist for further management.65FemaleCaucasian"
    },
    "2208": {
        "explanation_text": "Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes.",
        "symptom_text": "The patient has a history of breast cancer treated five years ago with surgery and chemotherapy.The patient reports painless swelling in the left armpit and upper arm for the past two months.Ultrasound of the left axilla and upper limb lymph nodes shows enlarged lymph nodes with suspicious features.Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes (C773): The patient presents with painless swelling in the left armpit and upper arm. Ultrasound findings indicate enlarged lymph nodes with suspicious features, consistent with a secondary malignant neoplasm in the axilla and upper limb lymph nodes.The patient's medical history of breast cancer raises concern for secondary neoplastic involvement in the axilla and upper limb lymph nodes. Further imaging studies and a biopsy are recommended for definitive diagnosis.Biopsy of the enlarged lymph nodes is scheduled to confirm the diagnosis. Referral to an oncologist for treatment planning.58FemaleCaucasian"
    },
    "2209": {
        "explanation_text": "Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes.",
        "symptom_text": "The patient has a history of metastatic melanoma diagnosed two years ago, which was treated with surgical excision and adjuvant therapy.The patient reports painless swelling in the right groin and right thigh for the last three weeks. No associated fever, weight loss, or night sweats.Ultrasound of the right groin and thigh showed multiple enlarged lymph nodes with central necrosis. Biopsy confirmed metastatic melanoma involvement.Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodesThe patient's physical examination revealed palpable lymphadenopathy in the right inguinal region and along the right femoral chain. No other palpable lymph nodes in other regions. No hepatomegaly or splenomegaly noted.The patient is planned for radiation therapy to the right inguinal and femoral lymph nodes followed by systemic immunotherapy.The patient tolerated treatment well without any significant adverse effects. Discharged with a plan for regular follow-up and monitoring of treatment response.56MaleCaucasian"
    },
    "2210": {
        "explanation_text": "Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes.",
        "symptom_text": "The patient has a history of prostate cancer treated with radiation therapy five years ago.The patient complains of persistent lower back pain and swelling in the groin area.CT scan revealed enlarged intrapelvic lymph nodes with irregular borders.Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes.Patient's physical examination shows palpable lymphadenopathy in the pelvic region. Biopsy results confirm metastatic spread to the intrapelvic lymph nodes.Initiated chemotherapy regimen targeting the intrapelvic lymph nodes.Patient responded well to treatment, and symptoms improved. Discharged with a follow-up plan for chemotherapy cycles.67MaleCaucasian"
    },
    "2211": {
        "explanation_text": "Secondary malignant neoplasm of unspecified lung.",
        "symptom_text": "The patient has a history of primary lung cancer treated with surgery and chemotherapy three years ago.The patient is asymptomatic and denies any respiratory complaints.CT scan of the chest revealed a solitary mass in the right lung with no other abnormalities detected.Secondary malignant neoplasm of unspecified lung. The presence of a solitary lung mass on imaging in a patient with a history of primary lung cancer supports the diagnosis of a secondary lung malignancy. There are no symptoms or findings suggestive of other specific lung sites or lymph node involvement, justifying the use of the unspecified lung code C7800.The patient's physical examination is unremarkable. No lymphadenopathy or other abnormal findings were noted.The patient will undergo a biopsy of the lung mass for histopathological confirmation and treatment planning.The patient is scheduled for a lung biopsy and will follow up in the oncology clinic for further management.65FemaleCaucasian"
    },
    "2212": {
        "explanation_text": "Secondary malignant neoplasm of left lung.",
        "symptom_text": "The patient has a history of primary lung cancer treated with surgery and chemotherapy.The patient presents with a persistent cough, hemoptysis, and left-sided chest pain.CT scan of the chest shows a mass in the left lung with no evidence of metastasis to other organs.Secondary malignant neoplasm of left lungThe neoplasm is localized in the left lung based on imaging studies and biopsy results.The patient is scheduled for radiation therapy targeting the left lung neoplasm.The patient responded well to treatment, and the left lung neoplasm is stable upon discharge.65FemaleCaucasian"
    },
    "2213": {
        "explanation_text": "Secondary malignant neoplasm of mediastinum.",
        "symptom_text": "The patient has a history of primary lung cancer treated with surgery and chemotherapy six years ago. No other significant medical history reported.The patient presented with persistent dry cough, chest pain, and shortness of breath. No other symptoms reported.CT scan of the chest revealed a 5 cm mass in the mediastinum with no other metastases detected.Secondary malignant neoplasm of mediastinum (C781): A secondary malignancy originating from a distant primary cancer site, presenting as a mass in the mediastinum without involvement of adjacent structures. The verbatim EHR quote justifying the code: 'CT scan confirmed a 5 cm mass in the mediastinum, consistent with secondary malignant neoplasm.'The oncologist noted the need for a biopsy to confirm the secondary nature of the mediastinal mass and to guide further treatment decisions.The patient was scheduled for a mediastinal mass biopsy to determine the histology and plan appropriate treatment based on the results.The patient's condition remained stable throughout the hospital stay. Discharge was planned post-biopsy results for further oncological management.64FemaleCaucasian"
    },
    "2214": {
        "explanation_text": "Secondary malignant neoplasm of pleura.",
        "symptom_text": "The patient has a history of primary lung adenocarcinoma diagnosed and treated six months ago.The patient complains of progressive shortness of breath and pleuritic chest pain.CT scan of the chest shows pleural thickening and pleural effusion. Pleural biopsy confirms metastatic adenocarcinoma consistent with the primary lung cancer.Secondary malignant neoplasm of pleura (ICD-10-CM code C782): 'Neoplasm of uncertain behavior of pleura' - This code is used for cases where the malignant neoplasm has spread to the pleura from a primary site.The patient's symptoms and diagnostic tests are consistent with metastasis to the pleura from the previously treated lung adenocarcinoma.The patient is scheduled for chemotherapy and pleurodesis to manage the pleural effusion.The patient was discharged in stable condition with a follow-up appointment in the oncology clinic next week.65MaleCaucasian"
    },
    "2215": {
        "explanation_text": "Secondary malignant neoplasm of other digestive organs.",
        "symptom_text": "The patient has a history of colorectal cancer treated with surgery and chemotherapy.The patient complains of persistent abdominal pain, unintentional weight loss, and loss of appetite.CT scan of the abdomen reveals a single metastatic lesion in the small intestine.Secondary malignant neoplasm of other digestive organs. The CT scan shows a metastatic lesion in the small intestine, consistent with the patient's history of colorectal cancer.The patient's symptoms and imaging findings are indicative of a secondary malignancy in the digestive organs, likely a metastasis from the previous colorectal cancer.The patient is scheduled for surgical resection of the metastatic lesion followed by targeted chemotherapy.The patient underwent successful surgical removal of the metastatic lesion and is recovering well postoperatively.65FemaleCaucasian"
    },
    "2216": {
        "explanation_text": "Secondary malignant neoplasm of right kidney and renal pelvis.",
        "symptom_text": "The patient has a history of primary malignant neoplasm of the bladder, for which they underwent a radical cystectomy five years ago.The patient is currently asymptomatic and is being monitored for recurrence of the primary malignancy.Recent CT scan of the abdomen revealed a solitary metastatic lesion in the right kidney and renal pelvis.Secondary malignant neoplasm of right kidney and renal pelvis.The patient's primary malignancy was bladder cancer, and the current finding of a metastatic lesion in the right kidney and renal pelvis is consistent with a secondary malignancy.The patient is scheduled for a nephrectomy to remove the metastatic lesion.The patient is stable post-surgery and will follow up for oncology consultations regularly.67FemaleCaucasian"
    },
    "2217": {
        "explanation_text": "Secondary malignant neoplasm of left kidney and renal pelvis.",
        "symptom_text": "The patient has a history of metastatic cancer from a primary tumor in the left kidney and renal pelvis.The patient is asymptomatic and is being monitored for disease progression.Imaging studies show metastasis to the left kidney and renal pelvis.Secondary malignant neoplasm of left kidney and renal pelvis.The patient is stable with no new complaints or symptoms. Close monitoring is advised to track the progression of the metastatic disease.The patient is currently under observation with regular imaging studies to monitor the metastatic spread. Palliative care is being discussed with the patient.68FemaleCaucasian"
    },
    "2218": {
        "explanation_text": "Secondary malignant neoplasm of bladder.",
        "symptom_text": "The patient has a history of primary malignant neoplasm in another organ, which has now metastasized to the bladder.The patient presents with hematuria, dysuria, and pelvic pain.CT scan shows a bladder mass with features consistent with metastatic disease.Secondary malignant neoplasm of bladder (C7911) - The patient has a history of primary malignant neoplasm in another organ, which has metastasized to the bladder.The patient's symptoms and diagnostic test results are indicative of metastatic disease to the bladder. No other primary malignancy in the bladder is identified.The patient is scheduled for chemotherapy to manage the metastatic disease in the bladder.The patient is stable post-treatment and will follow up for further oncology management.65FemaleCaucasian"
    },
    "2219": {
        "explanation_text": "Secondary malignant neoplasm of other urinary organs.",
        "symptom_text": "The patient has a history of primary malignant neoplasm in another organ, which has now metastasized to the urinary organs.The patient presents with hematuria, flank pain, and urinary frequency.Imaging studies reveal a mass in the urinary tract, and a biopsy confirms the presence of metastatic cancer cells consistent with the primary tumor.Secondary malignant neoplasm of other urinary organs. Verbatim EHR quote: 'Metastatic cancer to the urinary organs confirmed by biopsy.'The patient's primary tumor was previously treated with surgery and chemotherapy. The current presentation is consistent with metastasis to the urinary organs.The patient is scheduled for radiation therapy to target the metastatic lesion in the urinary organs.The patient responded well to treatment and is scheduled for follow-up monitoring to assess the response to radiation therapy.62MaleCaucasian"
    },
    "2220": {
        "explanation_text": "Secondary malignant neoplasm of cerebral meninges.",
        "symptom_text": "The patient has a history of primary lung adenocarcinoma diagnosed three years ago, which was treated with chemotherapy and radiation therapy.The patient presented with new-onset severe headaches, nausea, vomiting, and focal neurological deficits, including right-sided weakness and speech difficulties.MRI of the brain revealed a contrast-enhancing mass along the cerebral meninges, consistent with leptomeningeal metastasis. Cerebrospinal fluid analysis showed malignant cells.Secondary malignant neoplasm of cerebral meninges (ICD-10-CM code C7932): Neoplasm involving the cerebral meninges, causing headaches, focal neurological deficits, and confirmed by imaging and CSF analysis.The neurologist confirmed the diagnosis of leptomeningeal metastasis based on imaging findings and CSF analysis. The patient's symptoms correlate with the location of the metastasis along the cerebral meninges.The patient was started on intrathecal chemotherapy for leptomeningeal metastasis and was referred for palliative care.The patient's condition is stable post-treatment initiation. Discharge to home with close follow-up for symptom management and supportive care.65FemaleCaucasian"
    },
    "2221": {
        "explanation_text": "Secondary malignant neoplasm of other parts of nervous system.",
        "symptom_text": "The patient has a history of primary cancer in a different location, which has now metastasized to the nervous system.The patient presents with symptoms such as severe headaches, seizures, focal neurological deficits, and altered mental status.MRI of the brain and spine shows multiple enhancing lesions consistent with metastatic disease to the nervous system.Secondary malignant neoplasm of other parts of nervous system. Verbatim EHR quote justifying the code: 'MRI findings reveal multiple enhancing lesions in the brain and spine, indicative of metastatic involvement of the nervous system.'The neurologist documented the presence of neurological deficits corresponding to the areas where the lesions are located, confirming the diagnosis of metastatic neoplasm in the nervous system.The patient is scheduled for radiation therapy to target the metastatic lesions in the nervous system. Symptomatic management with antiepileptic drugs and corticosteroids is initiated to alleviate symptoms and reduce edema.The patient responded well to treatment and is planned for regular follow-up to monitor the response to radiation therapy and symptom management.58 yearsMaleCaucasian"
    },
    "2222": {
        "explanation_text": "Secondary malignant neoplasm of bone marrow.",
        "symptom_text": "The patient has a history of breast cancer diagnosed and treated two years ago.The patient presents with fatigue, easy bruising, and recurrent infections.Bone marrow biopsy results show infiltration of breast cancer cells.Secondary malignant neoplasm of bone marrow (C7952): 'C79.52 Secondary malignant neoplasm of bone marrow' as per bone marrow biopsy results confirming breast cancer metastasis to the bone marrow.Patient's history of breast cancer indicates a high likelihood of metastasis to distant sites. Symptoms of fatigue, bruising, and infections are consistent with bone marrow involvement.Initiated chemotherapy regimen targeting breast cancer metastasis to the bone marrow. Supportive care for symptoms provided.Patient responded well to treatment, with improvement in symptoms. Discharged with a follow-up plan for chemotherapy cycles and monitoring of bone marrow function.58 yearsFemaleCaucasian"
    },
    "2223": {
        "explanation_text": "Secondary malignant neoplasm of unspecified ovary.",
        "symptom_text": "The patient has a history of breast cancer treated five years ago with surgery and chemotherapy. No other significant medical history reported.The patient is currently asymptomatic and denies any abdominal pain, bloating, urinary symptoms, or neurological deficits.CT scan of the abdomen and pelvis revealed a 3 cm mass in the right ovary with no evidence of metastasis to other organs.Secondary malignant neoplasm of unspecified ovary. The neoplasm is located in the right ovary, as confirmed by imaging studies.The patient's physical examination was unremarkable. No palpable masses or tenderness on abdominal examination. The patient is in good general condition.The patient is scheduled for a right salpingo-oophorectomy to remove the ovarian mass. Oncology consultation has been requested for further management.The patient is scheduled for surgery and will follow up with the oncology team postoperatively.58FemaleCaucasian"
    },
    "2224": {
        "explanation_text": "Secondary malignant neoplasm of right ovary.",
        "symptom_text": "The patient has a history of primary ovarian cancer treated with surgery and chemotherapy.The patient reports right lower abdominal pain and bloating.CT scan shows a mass in the right ovary with no evidence of metastasis to other organs.Secondary malignant neoplasm of right ovaryOn physical examination, a palpable mass is noted in the right lower abdomen. The patient's CA-125 levels are elevated. Imaging confirms a solitary mass in the right ovary without involvement of other structures.The patient is scheduled for surgical resection of the right ovarian mass followed by adjuvant chemotherapy.The patient underwent successful surgery without complications and is planned for further oncological management.56FemaleCaucasian"
    },
    "2225": {
        "explanation_text": "Secondary malignant neoplasm of left ovary.",
        "symptom_text": "The patient has a history of breast cancer treated five years ago with surgery and chemotherapy. No other significant medical history reported.The patient presented with left lower abdominal pain and bloating for the past two months. No other symptoms reported.CT scan of the abdomen revealed a 5 cm mass in the left ovary with no evidence of metastasis to other organs.Secondary malignant neoplasm of left ovary. Verbatim_EHR_quote_justifying_the_code: 'CT scan confirmed a 5 cm mass in the left ovary, consistent with secondary malignant neoplasm.'Patient reports no family history of ovarian cancer. Physical examination showed tenderness in the left lower abdomen. No other significant findings noted.Patient scheduled for left oophorectomy followed by adjuvant chemotherapy.Patient underwent successful left oophorectomy without complications. Discharged with a plan for further oncological follow-up.58FemaleCaucasian"
    },
    "2226": {
        "explanation_text": "Secondary malignant neoplasm of unspecified adrenal gland.",
        "symptom_text": "The patient has a history of primary lung cancer diagnosed and treated six months ago.The patient presented with fatigue, unexplained weight loss, and abdominal pain.CT scan revealed a mass in the right adrenal gland.Secondary malignant neoplasm of unspecified adrenal glandThe patient's symptoms and diagnostic imaging findings are consistent with metastasis to the adrenal gland. No other primary malignancy was identified in the adrenal gland.The patient was started on chemotherapy targeting the adrenal gland metastasis.The patient was discharged in stable condition with close follow-up for chemotherapy response assessment.58MaleCaucasian"
    },
    "2227": {
        "explanation_text": "Secondary malignant neoplasm of right adrenal gland.",
        "symptom_text": "The patient has a history of primary lung cancer diagnosed and treated six months ago.The patient is currently asymptomatic and is here for a routine follow-up visit.Recent CT scan of the abdomen revealed a 3 cm mass in the right adrenal gland.Secondary malignant neoplasm of right adrenal glandPatient is stable and does not report any new symptoms. The CT scan confirmed the presence of a mass in the right adrenal gland consistent with metastasis from the known primary lung cancer.No immediate treatment is required. Patient advised to continue regular follow-ups for monitoring.The patient is discharged in good condition with instructions to follow up in three months for a repeat CT scan.58FemaleCaucasian"
    },
    "2228": {
        "explanation_text": "Secondary malignant neoplasm of left adrenal gland.",
        "symptom_text": "The patient has a history of primary lung adenocarcinoma diagnosed two years ago, for which they underwent surgical resection and adjuvant chemotherapy. No other significant medical history reported.The patient is currently asymptomatic and denies any new complaints or symptoms related to the adrenal gland.Recent CT scan of the abdomen revealed a 3 cm left adrenal mass with imaging characteristics suggestive of metastasis. No other concerning findings in the abdomen or pelvis.Secondary malignant neoplasm of left adrenal glandPatient's primary lung adenocarcinoma was in remission until the discovery of the left adrenal mass. No symptoms such as headaches, visual disturbances, or focal neurological deficits to suggest brain or central nervous system involvement.The patient is scheduled for a left adrenalectomy to remove the metastatic lesion. Oncology consult planned for consideration of further systemic therapy postoperatively.The patient underwent an uneventful left adrenalectomy and was discharged home in stable condition. Follow-up appointments scheduled with both surgical and oncology teams for postoperative care and treatment planning.58FemaleCaucasian"
    },
    "2229": {
        "explanation_text": "Secondary malignant neoplasm of genital organs.",
        "symptom_text": "The patient has a history of breast cancer (ICD-10-CM code C50) treated five years ago. No history of bone malignancies or ovarian tumors.The patient presents with pelvic pain, abnormal vaginal bleeding, and a palpable mass in the right lower abdomen.Pelvic ultrasound shows a large mass in the right ovary with no evidence of bone metastasis.Secondary malignant neoplasm of genital organs (ICD-10-CM code C7982): 'Secondary malignant neoplasm of genital organs' specifically refers to metastatic cancer involving the ovaries or other genital structures, which is supported by the patient's symptoms and imaging findings.Based on the patient's history of breast cancer, current symptoms, and imaging results, the diagnosis of secondary malignant neoplasm of the genital organs is established.The patient is scheduled for a laparoscopic right salpingo-oophorectomy followed by chemotherapy.The patient underwent successful surgery without complications and will continue treatment with the oncology team.58FemaleCaucasian"
    },
    "2230": {
        "explanation_text": "Secondary malignant neoplasm of other specified sites.",
        "symptom_text": "The patient has a history of primary malignant neoplasm treated with chemotherapy and radiation therapy.The patient is currently asymptomatic and is being monitored for any signs of metastasis.Recent CT scans and PET scans show a new lesion in the liver, raising suspicion of metastatic disease.Metastatic secondary malignant neoplasm of other specified sites (C7989).Patient is stable and will undergo further imaging studies to determine the extent of metastasis.Initiated consultation with oncology for consideration of targeted therapy.58FemaleCaucasian"
    },
    "2231": {
        "explanation_text": "Secondary malignant neoplasm of unspecified site.",
        "symptom_text": "The patient has a history of primary malignant neoplasm, which is a risk factor for secondary malignant neoplasms.The patient presents with non-specific symptoms such as fatigue, weight loss, and generalized pain, typical of a secondary malignant neoplasm of unspecified site.Imaging studies reveal multiple metastatic lesions in different organs, consistent with a secondary malignant neoplasm of unspecified site.Secondary malignant neoplasm of unspecified site (C799): 'C79.9 Secondary malignant neoplasm of unspecified site.'The patient's medical history of primary cancer, non-specific symptoms, and imaging findings support the diagnosis of a secondary malignant neoplasm of unspecified site.The patient is scheduled for further imaging to determine the extent of metastasis and will be referred to an oncologist for appropriate cancer treatment.N/A65FemaleCaucasian"
    },
    "2232": {
        "explanation_text": "Malignant carcinoid tumor of the ileum.",
        "symptom_text": "The patient has a history of intermittent abdominal pain, flushing, and diarrhea for the past six months. No other significant medical history reported.The patient presents with persistent abdominal pain, diarrhea, occasional flushing, and unintentional weight loss.CT scan of the abdomen revealed a well-defined mass in the ileum with mesenteric lymph node involvement. Biopsy results confirmed a well-differentiated neuroendocrine tumor consistent with a carcinoid tumor.Malignant carcinoid tumor of the ileum (C7A012): 'Malignant carcinoid tumor of the ileum' is confirmed based on the biopsy results showing a well-differentiated neuroendocrine tumor arising from the ileum.The patient's symptoms and diagnostic findings align with a well-differentiated neuroendocrine tumor of the ileum. No evidence of metastasis to other organs based on imaging studies.Surgical resection of the ileal mass is planned followed by close monitoring for recurrence or metastasis.The patient is scheduled for surgery to remove the carcinoid tumor of the ileum. Close follow-up will be essential to monitor the patient's condition postoperatively.55FemaleCaucasian"
    },
    "2233": {
        "explanation_text": "Malignant carcinoid tumor of the bronchus and lung.",
        "symptom_text": "The patient has a history of smoking for 20 years.The patient presented with persistent cough, wheezing, and hemoptysis.CT scan revealed a 4 cm mass in the right bronchus with no distant metastasis.Malignant carcinoid tumor of the bronchus and lung. Verbatim from ICD-10-CM: 'C7A090 - Malignant carcinoid tumor of the bronchus and lung.'The patient's symptoms and imaging findings are consistent with a primary bronchial carcinoid tumor.Surgical resection of the bronchial tumor followed by adjuvant chemotherapy.The patient recovered well post-surgery and was discharged with a follow-up plan for chemotherapy cycles.55MaleCaucasian"
    },
    "2234": {
        "explanation_text": "Other malignant neuroendocrine tumors.",
        "symptom_text": "The patient has a history of chronic abdominal pain and unintentional weight loss over the past six months. No history of adrenal gland, breast, genital organs, or other specified sites malignancies.The patient presents with persistent abdominal pain, flushing, and diarrhea. No symptoms suggestive of carcinoid tumors in the ileum, small intestine, bronchus, lung, or other organs.CT scan revealed a 5 cm mass in the small intestine with liver metastases. Elevated chromogranin A levels and 24-hour urine 5-HIAA levels were consistent with neuroendocrine tumor activity.Other malignant neuroendocrine tumors (C7A8): 'This is a primary malignant neuroendocrine tumor of the small intestine with liver metastases.'The patient's symptoms and diagnostic tests are consistent with a primary malignant neuroendocrine tumor of the small intestine with liver metastases. No evidence of secondary carcinoid tumors in distant lymph nodes, liver, bone, or peritoneum.The patient is scheduled for surgical resection of the small intestine tumor. Subsequently, they will undergo liver-directed therapies for the metastases.The patient underwent successful surgery without complications. They are recovering well and will follow up for further treatment of the liver metastases.56FemaleCaucasian"
    },
    "2235": {
        "explanation_text": "Secondary carcinoid tumors of distant lymph nodes.",
        "symptom_text": "The patient has a history of midgut carcinoid tumors treated with surgery and somatostatin analogs.The patient reports abdominal pain, flushing, and diarrhea.CT scan shows multiple enlarged lymph nodes in the mediastinum and retroperitoneum.Secondary carcinoid tumors of distant lymph nodes. Verbatim_EHR_quote_justifying_the_code: 'CT scan confirmed the presence of multiple enlarged lymph nodes in the mediastinum and retroperitoneum, consistent with distant lymph node metastasis.'Patient presents with symptoms consistent with carcinoid syndrome. No signs of liver involvement or primary ileal tumor.Initiated on octreotide for symptom control and referred to oncology for further management.Patient discharged in stable condition with close follow-up for treatment monitoring.58FemaleCaucasian"
    },
    "2236": {
        "explanation_text": "Secondary carcinoid tumors of liver.",
        "symptom_text": "The patient has a history of primary carcinoid tumor of the small intestine diagnosed two years ago.The patient presents with right upper quadrant abdominal pain, jaundice, and unintentional weight loss.CT scan of the abdomen shows multiple liver lesions consistent with metastatic disease. Liver biopsy confirms the presence of secondary carcinoid tumors.Secondary carcinoid tumors of liver (C7B02): The liver biopsy results confirm the presence of secondary carcinoid tumors in the liver.The patient's primary carcinoid tumor of the small intestine was resected two years ago. Current symptoms and imaging findings are consistent with metastatic carcinoid tumors involving the liver.Started on monthly octreotide injections for symptom management. Referred to oncology for consideration of systemic therapy.The patient was discharged in stable condition with close follow-up with the oncology team for further management of the secondary carcinoid tumors of the liver.58FemaleCaucasian"
    },
    "2237": {
        "explanation_text": "Secondary carcinoid tumors of other sites.",
        "symptom_text": "The patient has a history of primary carcinoid tumor of the small intestine treated surgically two years ago.The patient is currently asymptomatic and is being monitored for recurrence.Recent CT scan showed a single 2 cm lesion in the liver, consistent with a metastatic carcinoid tumor.Secondary carcinoid tumors of other sites (C7B09): 'Carcinoid tumors are classified to code C7B09 when they have metastasized to sites other than the liver, bone, or distant lymph nodes.'Patient reports no new symptoms. Physical examination unremarkable. Plan for close surveillance with imaging every 6 months.No active treatment initiated currently. Advised on signs of carcinoid syndrome and to return if any symptoms develop.58FemaleCaucasian"
    },
    "2238": {
        "explanation_text": "Other secondary neuroendocrine tumors.",
        "symptom_text": "The patient has a history of primary neuroendocrine tumor of the pancreas, diagnosed and treated two years ago.The patient is currently asymptomatic and is being monitored for any signs of tumor recurrence or metastasis.Recent CT scans of the abdomen and pelvis show no evidence of local recurrence or distant metastasis.Other secondary neuroendocrine tumors (ICD-10-CM code C7B8) - Verbatim EHR quote justifying the code: 'Patient presents with a history of primary neuroendocrine tumor of the pancreas, now with no evidence of local recurrence or distant metastasis, consistent with a diagnosis of other secondary neuroendocrine tumors.'Patient is compliant with follow-up appointments and surveillance imaging. No new complaints or concerning symptoms reported.No active treatment is indicated at this time. The patient will continue with regular follow-up visits for monitoring.No hospitalization was required. Patient was discharged home with instructions for follow-up visits and imaging studies as scheduled.58FemaleCaucasian"
    },
    "2239": {
        "explanation_text": "Disseminated malignant neoplasm, unspecified.",
        "symptom_text": "The patient has a history of chronic back pain and fatigue, which prompted further investigation.The patient presented with unexplained weight loss, night sweats, and generalized lymphadenopathy.PET scan showed multiple hypermetabolic lesions involving various organs, including the liver, bones, and lungs.Disseminated malignant neoplasm, unspecified (ICD-10-CM code C800).The patient's condition is consistent with widespread metastasis, and further workup is needed to determine the primary tumor site.Initiated chemotherapy regimen tailored to treat disseminated malignancies.The patient was discharged with close follow-up for response to chemotherapy and monitoring for treatment-related side effects.56MaleCaucasian"
    },
    "2240": {
        "explanation_text": "Malignant (primary) neoplasm, unspecified.",
        "symptom_text": "The patient has a history of smoking for 20 years.The patient presented with unexplained weight loss and fatigue.CT scan revealed a mass in the lung, and biopsy confirmed malignancy.Malignant (primary) neoplasm, unspecified. Verbatim_EHR_quote_justifying_the_code: 'The biopsy results confirmed the presence of a malignant neoplasm in the lung without specifying the exact type or site.'The patient is scheduled for further staging tests to determine the extent of the neoplasm.The patient will undergo chemotherapy and radiation therapy for the malignant neoplasm.N/A55MaleCaucasian"
    },
    "2241": {
        "explanation_text": "Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of painless swelling of multiple lymph nodes over the past few months.The patient presents with painless swelling of lymph nodes in the neck, armpits, and groin. Additionally, the patient reports intermittent fevers, unintentional weight loss, and night sweats.CT scans revealed multiple enlarged lymph nodes in the neck, axilla, and inguinal regions. A lymph node biopsy was performed, showing Reed-Sternberg cells and a background of nodular sclerosis.Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites (C8118): The lymph node biopsy demonstrated Reed-Sternberg cells and nodular sclerosis consistent with nodular sclerosis Hodgkin lymphoma.Histopathological examination of the lymph node biopsy confirmed the presence of Reed-Sternberg cells and lacunar cells characteristic of nodular sclerosis Hodgkin lymphoma. The patient's symptoms align with the typical presentation of this subtype of Hodgkin lymphoma.The patient will start chemotherapy with ABVD regimen (doxorubicin, bleomycin, vinblastine, dacarbazine) for nodular sclerosis Hodgkin lymphoma.The patient responded well to the first cycle of chemotherapy and will continue treatment on an outpatient basis. Close follow-up is scheduled to monitor treatment response and manage any side effects.32FemaleCaucasian"
    },
    "2242": {
        "explanation_text": "Hodgkin lymphoma, unspecified, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of intermittent night sweats and unexplained weight loss over the past 3 months.The patient presents with painless, enlarged lymph nodes in the neck, armpits, and groin. No pruritus or alcohol-induced pain reported.CT scan shows enlarged lymph nodes in multiple regions. Biopsy results indicate the presence of Reed-Sternberg cells.Hodgkin lymphoma, unspecified, lymph nodes of multiple sites (C8198): The Reed-Sternberg cells found in the biopsy results confirm the diagnosis of Hodgkin lymphoma, unspecified, involving lymph nodes in multiple sites.The patient's physical examination revealed firm, rubbery lymph nodes in various locations. No hepatomegaly or splenomegaly noted.The patient is scheduled for chemotherapy following the standard protocol for Hodgkin lymphoma.The patient responded well to treatment and is scheduled for regular follow-up appointments for monitoring and further management.34MaleCaucasian"
    },
    "2243": {
        "explanation_text": "Follicular lymphoma grade IIIa, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of gradually enlarging painless lymph nodes in multiple areas of the body over the past few months.Presented with fatigue, unintentional weight loss, and night sweats. Denies fevers, itching, or alcohol-induced pain.Excisional biopsy of a cervical lymph node shows a diffuse proliferation of small cleaved cells with irregular nuclei and scant cytoplasm. Immunohistochemistry is positive for CD10, BCL2, and BCL6.Follicular lymphoma grade IIIa, lymph nodes of multiple sites. The lymphoma cells are small to medium-sized with irregular nuclei and a high proliferation index.The patient's physical examination revealed multiple discrete rubbery lymph nodes in the cervical, axillary, and inguinal regions. No hepatosplenomegaly noted.Initiated on rituximab plus chemotherapy regimen. Scheduled for regular follow-up visits and monitoring of treatment response.The patient was discharged in stable condition with close outpatient follow-up for ongoing management of Follicular lymphoma grade IIIa.58FemaleCaucasian"
    },
    "2244": {
        "explanation_text": "Follicular lymphoma, unspecified, unspecified site.",
        "symptom_text": "The patient has a history of intermittent painless swelling of cervical lymph nodes over the past six months.The patient presents with fatigue and unintentional weight loss of 10 pounds in the last three months.Lymph node biopsy revealed a nodular growth pattern of small cleaved cells with irregular nuclei consistent with follicular lymphoma.Follicular lymphoma, unspecified, unspecified site (C8290): The lymph node biopsy showed a nodular growth pattern of small cleaved cells with irregular nuclei, consistent with follicular lymphoma.Physical examination revealed painless bilateral cervical lymphadenopathy. No hepatosplenomegaly noted.The patient is scheduled to start rituximab and bendamustine chemotherapy regimen.The patient responded well to the first cycle of chemotherapy with a reduction in lymph node size and improvement in symptoms. Discharged home with a scheduled follow-up in two weeks.56FemaleCaucasian"
    },
    "2245": {
        "explanation_text": "Follicular lymphoma, unspecified, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of gradually enlarging painless lymph nodes in multiple areas of the body over the past few months.The patient presents with painless swelling in the neck, armpits, and groin.Excisional biopsy of a cervical lymph node shows a nodular growth pattern with a mixture of centrocytes and centroblasts. Immunohistochemistry is positive for CD10 and BCL2.Follicular lymphoma, unspecified, lymph nodes of multiple sites: The exact quote from the EHR justifying the code is: 'Excisional biopsy of a cervical lymph node shows a nodular growth pattern with a mixture of centrocytes and centroblasts. Immunohistochemistry is positive for CD10 and BCL2.'The physician noted painless lymphadenopathy in multiple sites without any systemic symptoms. No hepatosplenomegaly or B symptoms are present.The patient is planned for rituximab-based immunotherapy followed by watchful waiting.The patient was discharged with a follow-up appointment in two weeks to assess the response to the initial treatment.56FemaleCaucasian"
    },
    "2246": {
        "explanation_text": "Follicular lymphoma, unspecified, extranodal and solid organ sites.",
        "symptom_text": "The patient has a history of intermittent night sweats and unintentional weight loss over the past six months. No history of prior malignancies or autoimmune diseases.The patient presents with painless swelling in the left inguinal region and mild fatigue. No pruritus, night sweats, or fever reported.CT scan reveals multiple enlarged lymph nodes in the left inguinal region and a solid mass in the liver. Biopsy results confirm a diagnosis of follicular lymphoma involving extranodal and solid organ sites.Follicular lymphoma, unspecified, extranodal and solid organ sites. Verbatim EHR quote justifying the code: 'Biopsy results confirm a diagnosis of follicular lymphoma involving extranodal and solid organ sites.'Patient reports mild discomfort in the left inguinal region but denies any B symptoms. Physical examination shows palpable lymph nodes in the left inguinal area and hepatomegaly.The patient will start immunochemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP regimen). Regular follow-ups and monitoring of liver function tests are planned.The patient responded well to the first cycle of R-CHOP therapy with a reduction in lymph node size and no signs of tumor lysis syndrome. Discharged home with a scheduled follow-up in two weeks.56FemaleCaucasian"
    },
    "2247": {
        "explanation_text": "Small cell B-cell lymphoma, unspecified site.",
        "symptom_text": "The patient has a history of recurrent fevers and unexplained weight loss over the past few months. No prior history of lymphomas or other malignancies.Presented with fatigue, night sweats, and generalized lymphadenopathy. Denies any respiratory or gastrointestinal symptoms.CT scan revealed multiple enlarged lymph nodes in the neck, axilla, and groin. Biopsy of a cervical lymph node showed small, uniform lymphoid cells with scant cytoplasm.Small cell B-cell lymphoma, unspecified site. Verbatim quote from ICD-10-CM: 'Small cell B-cell lymphoma, unspecified site is a mature B-cell neoplasm characterized by small- to medium-sized lymphoid cells with minimal cytoplasm and dense, uniform chromatin.'The patient's physical examination is significant for bilateral cervical, axillary, and inguinal lymphadenopathy. No hepatosplenomegaly noted. No B symptoms. No other remarkable findings on systemic review.Initiated on chemotherapy regimen R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) for Small cell B-cell lymphoma.The patient responded well to the initial cycle of chemotherapy without significant adverse effects. Discharged home with close follow-up for the upcoming cycles.58FemaleCaucasian"
    },
    "2248": {
        "explanation_text": "Small cell B-cell lymphoma, spleen.",
        "symptom_text": "The patient has a history of unexplained weight loss, fatigue, and night sweats over the past few months.The patient presents with splenomegaly, generalized lymphadenopathy, and easy bruising.CT scan showing splenomegaly and multiple enlarged lymph nodes. Biopsy results confirming Small cell B-cell lymphoma involving the spleen.Small cell B-cell lymphoma, spleen (C8307): The lymphoma involves the spleen and is characterized by small B-cells with a high nuclear to cytoplasmic ratio, confirming the diagnosis.The patient's physical examination revealed hepatosplenomegaly and palpable lymph nodes in multiple areas. The biopsy results from the spleen confirmed Small cell B-cell lymphoma.The patient is scheduled for chemotherapy with a regimen tailored for Small cell B-cell lymphoma. Close monitoring of blood counts and tumor markers will be initiated.The patient is stable post-biopsy and has been discharged with a detailed treatment plan. Follow-up appointments are scheduled to monitor treatment response and side effects.58FemaleCaucasian"
    },
    "2249": {
        "explanation_text": "Small cell B-cell lymphoma, extranodal and solid organ sites.",
        "symptom_text": "The patient has a history of intermittent night sweats and unintentional weight loss over the past 3 months.The patient presents with fatigue, generalized itching, and abdominal discomfort.CT scan revealed multiple solid organ masses in the liver and spleen. Biopsy results confirmed small cell B-cell lymphoma involving extranodal sites.Small cell B-cell lymphoma, extranodal and solid organ sites. Verbatim ICD-10-CM quote: 'C83.09 - Small cell B-cell lymphoma, extranodal and solid organ sites.'The patient's physical examination showed hepatosplenomegaly. No palpable lymphadenopathy was noted. The biopsy results confirmed the diagnosis of small cell B-cell lymphoma involving extranodal and solid organ sites.The patient is planned for chemotherapy with R-CHOP regimen starting next week.The patient tolerated the treatment well and was discharged with a scheduled follow-up in the oncology clinic in two weeks.58FemaleCaucasian"
    },
    "2250": {
        "explanation_text": "Mantle cell lymphoma, lymph nodes of head, face, and neck.",
        "symptom_text": "The patient has a history of gradually enlarging lymph nodes in the head, face, and neck region over the past few months.The patient presents with painless swelling of lymph nodes in the head, face, and neck area, along with fatigue and unintentional weight loss.Biopsy results indicate the presence of cyclin D1 overexpression, characteristic of Mantle cell lymphoma. Imaging studies show enlarged lymph nodes in the head, face, and neck regions.Mantle cell lymphoma, lymph nodes of head, face, and neck.Physical examination revealed firm, mobile lymph nodes in the head, face, and neck without any signs of inflammation. The patient has no B symptoms. Biopsy results confirm the diagnosis of Mantle cell lymphoma.The patient is planned for chemotherapy with a regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).The patient responded well to the initial cycle of chemotherapy and is scheduled for further treatment as an outpatient.58MaleCaucasian"
    },
    "2251": {
        "explanation_text": "Mantle cell lymphoma, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of chronic lymphocytic leukemia (CLL) diagnosed five years ago, which has been managed with chemotherapy and regular follow-ups.The patient presented with painless swelling of multiple lymph nodes in the neck, axilla, and groin regions. No B symptoms such as fever, night sweats, or weight loss were reported.CT scans revealed multiple enlarged lymph nodes in the neck, axilla, mediastinum, and abdomen. Excisional biopsy of a cervical lymph node showed cyclin D1 positivity on immunohistochemistry.Mantle cell lymphoma, lymph nodes of multiple sites. Verbatim: The excisional biopsy of a cervical lymph node showed cyclin D1 positivity on immunohistochemistry, confirming the diagnosis of Mantle cell lymphoma.The oncologist noted the characteristic immunophenotype of the tumor cells, including CD5, CD20, and cyclin D1 positivity. The patient's performance status is good, and no extranodal involvement was detected.The patient is planned for R-CHOP chemotherapy regimen followed by autologous stem cell transplantation.The patient tolerated the first cycle of chemotherapy well without any significant adverse effects and was discharged with a plan for regular follow-ups.67MaleCaucasian"
    },
    "2252": {
        "explanation_text": "Mantle cell lymphoma, extranodal and solid organ sites.",
        "symptom_text": "The patient has a history of chronic lymphocytic leukemia (CLL) diagnosed five years ago, which was treated with chemotherapy and achieved remission. No other significant medical history reported.The patient presented with abdominal pain, early satiety, and unintentional weight loss over the past three months. No fevers, night sweats, or enlarged lymph nodes were reported.CT scan of the abdomen revealed splenomegaly and multiple hypodense lesions in the liver. Biopsy of the liver lesions showed cyclin D1 positivity, confirming the diagnosis of Mantle cell lymphoma.Mantle cell lymphoma, extranodal and solid organ sites. The diagnosis is supported by the presence of cyclin D1 positivity in the liver lesions, consistent with Mantle cell lymphoma.The patient's physical examination was significant for splenomegaly without palpable lymphadenopathy. The absence of enlarged lymph nodes and the presence of extranodal involvement in the liver support the diagnosis of Mantle cell lymphoma in solid organ sites.The patient was started on a chemotherapy regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). Close monitoring of liver function tests and tumor markers was initiated.The patient responded well to the initial cycles of chemotherapy with a reduction in liver lesion size and improvement in symptoms. Discharged home with outpatient follow-up for continuation of chemotherapy.67MaleCaucasian"
    },
    "2253": {
        "explanation_text": "Diffuse large B-cell lymphoma, unspecified site.",
        "symptom_text": "The patient has a history of intermittent night sweats, unintentional weight loss, and generalized weakness over the past few months.Presented with fatigue, shortness of breath, and painless swelling of multiple lymph nodes.CT scan revealed enlarged lymph nodes in the neck, axilla, and abdomen. Biopsy confirmed the presence of large B-cells.Diffuse large B-cell lymphoma, unspecified site. The diagnosis is supported by the presence of large B-cells on biopsy and the characteristic symptoms of fatigue, shortness of breath, and painless lymphadenopathy.The patient responded well to the first cycle of R-CHOP chemotherapy with a reduction in lymph node size and improvement in symptoms.Started on R-CHOP chemotherapy regimen. Supportive care provided for symptom management.The patient was discharged in stable condition with arrangements for follow-up chemotherapy cycles at the outpatient clinic.58FemaleCaucasian"
    },
    "2254": {
        "explanation_text": "Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck.",
        "symptom_text": "The patient has a history of recurrent fevers, night sweats, and unexplained weight loss over the past few months.The patient presents with painless swelling of lymph nodes in the head, face, and neck regions. There are no other significant symptoms reported.Biopsy results confirm the presence of Diffuse large B-cell lymphoma in the lymph nodes of the head, face, and neck.Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck. Verbatim EHR quote justifying the code: 'Biopsy results confirm the presence of Diffuse large B-cell lymphoma in the lymph nodes of the head, face, and neck.'The oncologist notes the characteristic histological features of Diffuse large B-cell lymphoma on the biopsy samples from the head, face, and neck lymph nodes.The patient is scheduled for chemotherapy with R-CHOP regimen followed by radiation therapy.The patient responded well to treatment and is planned for regular follow-ups to monitor the response to therapy.58FemaleCaucasian"
    },
    "2255": {
        "explanation_text": "Diffuse large B-cell lymphoma, intrathoracic lymph nodes.",
        "symptom_text": "The patient has a history of unexplained weight loss and night sweats over the past few months.The patient presents with fatigue, shortness of breath, and a persistent cough.CT scan of the chest revealed enlarged lymph nodes in the mediastinum and hila.Diffuse large B-cell lymphoma, intrathoracic lymph nodes (C8332): The lymphoma involves the intrathoracic lymph nodes.The patient's CT scan confirmed the presence of Diffuse large B-cell lymphoma in the intrathoracic lymph nodes. Biopsy results are pending for further confirmation.The patient is scheduled for chemotherapy with R-CHOP regimen.The patient tolerated chemotherapy well and was discharged in stable condition.58MaleCaucasian"
    },
    "2256": {
        "explanation_text": "Diffuse large B-cell lymphoma, intra-abdominal lymph nodes.",
        "symptom_text": "The patient has a history of intermittent abdominal pain and unintentional weight loss over the past three months.The patient presents with abdominal fullness, night sweats, and fatigue.CT scan of the abdomen revealed enlarged intra-abdominal lymph nodes with no evidence of splenic or hepatic involvement.Diffuse large B-cell lymphoma, intra-abdominal lymph nodes (C8333): The patient presents with abdominal fullness, night sweats, and fatigue. CT scan confirmed enlarged intra-abdominal lymph nodes.Histopathological examination of the lymph node biopsy showed a diffuse proliferation of large neoplastic B-cells, confirming the diagnosis of diffuse large B-cell lymphoma. The absence of cyclin D1 overexpression and characteristic genetic features of Burkitt lymphoma ruled out other differential diagnoses.The patient is scheduled to start R-CHOP chemotherapy regimen.The patient responded well to treatment and was discharged with a follow-up appointment in two weeks.58FemaleCaucasian"
    },
    "2257": {
        "explanation_text": "Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb.",
        "symptom_text": "The patient has a history of intermittent night sweats and unexplained weight loss over the past three months.The patient presents with painless swelling in the right axilla and right upper limb.Biopsy results indicate Diffuse large B-cell lymphoma involving the lymph nodes of the axilla and upper limb.Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb (C8334): The lymph node biopsy from the right axilla and upper limb shows diffuse infiltration of large B-cells with a high proliferation index, consistent with Diffuse large B-cell lymphoma.Upon physical examination, enlarged lymph nodes were palpated in the right axilla and upper limb. No hepatosplenomegaly was noted.The patient is scheduled to start R-CHOP chemotherapy regimen.The patient responded well to treatment and was discharged in stable condition.58FemaleCaucasian"
    },
    "2258": {
        "explanation_text": "Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb.",
        "symptom_text": "The patient has a history of unexplained weight loss, night sweats, and fatigue over the past few months.The patient presents with painless swelling in the inguinal region and lower limb, along with generalized lymphadenopathy.Biopsy results from the inguinal lymph node show a diffuse proliferation of large neoplastic B-cells, confirming the diagnosis of Diffuse large B-cell lymphoma.Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb (C8335): The lymph node biopsy revealed a diffuse proliferation of large neoplastic B-cells consistent with Diffuse large B-cell lymphoma involving the inguinal region and lower limb.The patient's physical examination is significant for firm, mobile lymph nodes in the inguinal area and lower limb. No other palpable lymphadenopathy is noted in other regions. There are no B symptoms present.The patient is planned for chemotherapy with R-CHOP regimen starting next week.58MaleCaucasian"
    },
    "2259": {
        "explanation_text": "Diffuse large B-cell lymphoma, spleen.",
        "symptom_text": "The patient has a history of intermittent abdominal pain and unexplained weight loss over the past few months.The patient presents with fatigue, night sweats, and abdominal fullness.CT scan of the abdomen shows splenomegaly with no evidence of lymphadenopathy in other regions. Biopsy of the spleen confirms the presence of diffuse large B-cell lymphoma.Diffuse large B-cell lymphoma of the spleen (C8337) - The spleen biopsy shows diffuse proliferation of large neoplastic lymphoid cells expressing B-cell markers, confirming the diagnosis of diffuse large B-cell lymphoma with the primary site being the spleen.The patient's physical examination is significant for splenomegaly with no palpable lymph nodes in other regions. The histopathology report of the spleen biopsy indicates a high proliferation index of large B-cell lymphoma cells.The patient is planned for chemotherapy with R-CHOP regimen starting next week.The patient tolerated the treatment well and is scheduled for regular follow-up visits to monitor the treatment response.58MaleCaucasian"
    },
    "2260": {
        "explanation_text": "Diffuse large B-cell lymphoma, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of intermittent night sweats and unintentional weight loss over the past six months. No other significant medical history reported.The patient presents with painless swelling of lymph nodes in the neck, axilla, and inguinal regions. There is no history of fevers, drenching night sweats, or pruritus.CT scans reveal enlarged lymph nodes in the neck, axilla, and inguinal regions. Biopsy results confirm the presence of large B-cell lymphoma cells in these multiple sites.Diffuse large B-cell lymphoma, lymph nodes of multiple sites. Verbatim EHR quote justifying the code: 'Biopsy results confirm the presence of large B-cell lymphoma cells in the neck, axilla, and inguinal regions.'The patient's physical examination is notable for multiple discrete, rubbery lymph nodes in the neck, axilla, and inguinal regions. No hepatosplenomegaly detected.The patient is scheduled to start R-CHOP chemotherapy regimen next week.The patient responded well to treatment and was discharged in stable condition.58FemaleCaucasian"
    },
    "2261": {
        "explanation_text": "Burkitt lymphoma, unspecified site.",
        "symptom_text": "The patient has no significant past medical history.The patient presented with a rapidly growing tumor on the jaw, along with jaw pain, fever, night sweats, and unintentional weight loss.Histopathological examination of the tumor revealed a starry-sky pattern on microscopy and positive immunohistochemical staining for B-cell markers. MYC translocation was also detected.Burkitt lymphoma, unspecified site. Verbatim EHR quote justifying the code: 'Histopathological examination revealed a starry-sky pattern on microscopy, positive immunohistochemical staining for B-cell markers, and MYC translocation, consistent with Burkitt lymphoma.'The oncologist noted the characteristic features of Burkitt lymphoma in the patient's presentation and test results.The patient was started on a chemotherapy regimen according to Burkitt lymphoma protocols.The patient responded well to treatment and was discharged with a follow-up plan for ongoing chemotherapy.35MaleCaucasian"
    },
    "2262": {
        "explanation_text": "Burkitt lymphoma, intra-abdominal lymph nodes.",
        "symptom_text": "The patient has no previous history of lymphoma or any other significant medical conditions. No family history of lymphoproliferative disorders.The patient presented with complaints of rapidly growing abdominal mass, night sweats, weight loss, and abdominal pain. No symptoms related to other lymphoma subtypes or sites.CT scan of the abdomen revealed a large mass in the intra-abdominal region involving multiple lymph nodes. Biopsy results confirmed the presence of Burkitt lymphoma with characteristic c-MYC translocation.Burkitt lymphoma, intra-abdominal lymph nodes. The diagnosis is supported by the presence of a rapidly growing abdominal mass, night sweats, weight loss, abdominal pain, and imaging and biopsy results indicating Burkitt lymphoma involving the intra-abdominal lymph nodes.The patient's physical examination was significant for a palpable mass in the abdomen, consistent with lymphadenopathy. No other palpable nodes in different regions. The patient has no hepatosplenomegaly or other organomegaly. No skin lesions or other extranodal involvement noted.The patient has been started on a chemotherapy regimen according to the R-CODOX-M/IVAC protocol. Close monitoring for tumor lysis syndrome initiated. Oncology consult scheduled for further management.The patient responded well to the initial chemotherapy cycles with a reduction in the size of the intra-abdominal mass. Discharged in stable condition with outpatient follow-up scheduled for continuation of chemotherapy.32 yearsMaleCaucasian"
    },
    "2263": {
        "explanation_text": "Burkitt lymphoma, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of intermittent fevers, night sweats, and unintentional weight loss over the past few months.The patient presented with rapidly growing painless swellings in the neck, groin, and abdomen. No other symptoms such as chest pain, dyspnea, or abdominal pain were reported.CT scans revealed multiple enlarged lymph nodes in the neck, axilla, groin, and abdomen. Biopsy results showed a high proliferation rate of medium-sized lymphoid cells with a starry sky appearance.Burkitt lymphoma, lymph nodes of multiple sites. Verbatim EHR quote justifying the code: 'Biopsy results confirmed Burkitt lymphoma with involvement of lymph nodes in the neck, axilla, groin, and abdomen.'The oncologist noted the characteristic histological features of Burkitt lymphoma on biopsy and recommended starting intensive chemotherapy.The patient was started on the R-CODOX-M/IVAC regimen for Burkitt lymphoma.The patient responded well to chemotherapy and was discharged with a plan for outpatient follow-up.32MaleCaucasian"
    },
    "2264": {
        "explanation_text": "Cutaneous T-cell lymphoma, unspecified, unspecified site.",
        "symptom_text": "The patient has a history of chronic skin changes and persistent rash over the last few months, with no improvement despite topical treatments.The patient presents with erythematous patches on the skin, accompanied by mild itching. There are no systemic symptoms like fever, weight loss, or night sweats.Skin biopsy results indicate atypical lymphoid cells with epidermotropism and Pautrier microabscesses, confirming the diagnosis of Cutaneous T-cell lymphoma.Cutaneous T-cell lymphoma, unspecified, unspecified site. Verbatim EHR quote justifying the code: 'Skin biopsy results indicate atypical lymphoid cells with epidermotropism and Pautrier microabscesses, confirming the diagnosis of Cutaneous T-cell lymphoma.'Physical examination reveals erythematous patches on the skin, primarily on the trunk and extremities. No palpable lymphadenopathy or organomegaly is noted. The patient is referred to an oncologist for further management.The patient is started on narrow-band UVB phototherapy for Cutaneous T-cell lymphoma. Emollients and topical steroids are prescribed for symptomatic relief.The patient responded well to phototherapy during the hospital stay. Discharge instructions include follow-up appointments with the oncologist for ongoing management of Cutaneous T-cell lymphoma.58FemaleCaucasian"
    },
    "2265": {
        "explanation_text": "Unspecified B-cell lymphoma, intra-abdominal lymph nodes.",
        "symptom_text": "The patient has a history of intermittent abdominal pain and unexplained weight loss over the past few months.The patient presents with persistent abdominal discomfort, early satiety, and palpable abdominal masses.CT scan of the abdomen reveals enlarged lymph nodes in the intra-abdominal region. Biopsy results confirm B-cell lymphoma involvement in the intra-abdominal lymph nodes.Unspecified B-cell lymphoma, intra-abdominal lymph nodes (C8513)The patient's symptoms, physical examination findings, and diagnostic test results are consistent with Unspecified B-cell lymphoma involving the intra-abdominal lymph nodes. No other specific lymphoma type or site is indicated.The patient is scheduled for chemotherapy targeting B-cell lymphoma. Consultation with an oncologist has been arranged for further management.The patient is stable and will follow up with the oncology department for further treatment.58FemaleCaucasian"
    },
    "2266": {
        "explanation_text": "Unspecified B-cell lymphoma, extranodal and solid organ sites.",
        "symptom_text": "The patient has a history of intermittent night sweats and unintentional weight loss over the past three months. No history of immunodeficiency disorders or previous lymphomas.The patient presents with fatigue, generalized lymphadenopathy, and a palpable abdominal mass. No symptoms of Burkitt lymphoma, mediastinal large B-cell lymphoma, or other specified types of non-Hodgkin lymphoma.CT scan shows a 10 cm mass in the abdomen with no mediastinal or skin involvement. Biopsy results indicate a diffuse proliferation of medium-sized lymphoid cells with irregular nuclei.Unspecified B-cell lymphoma, extranodal and solid organ sites: The lymphoma cells are positive for CD20 and negative for CD3, consistent with a diagnosis of Unspecified B-cell lymphoma. The absence of specific features of Burkitt lymphoma, mediastinal large B-cell lymphoma, or other specified types of non-Hodgkin lymphoma supports the classification as Unspecified B-cell lymphoma, extranodal and solid organ sites.The patient's presentation of B symptoms, generalized lymphadenopathy, and the histopathological findings of medium-sized lymphoid cells with CD20 positivity are consistent with Unspecified B-cell lymphoma, extranodal and solid organ sites. No features suggestive of other types of lymphomas are noted.The patient is planned for chemotherapy with R-CHOP regimen.The patient responded well to treatment and was discharged with close follow-up for chemotherapy cycles.58FemaleCaucasian"
    },
    "2267": {
        "explanation_text": "Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes.",
        "symptom_text": "The patient has a history of intermittent chest pain and unexplained weight loss over the past three months. No prior history of lymphoma or other malignancies reported.The patient presented with persistent cough, dyspnea, and superior vena cava syndrome, including facial swelling and distended neck veins.CT scan revealed a large anterior mediastinal mass measuring 8 cm with compression of adjacent structures. Biopsy confirmed large B-cell lymphoma involving intrathoracic lymph nodes.Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes (C8522)Patient shows no signs of Burkitt lymphoma, T-cell lymphoma, or unspecified lymphoma. The diagnosis is consistent with mediastinal involvement, large B-cell subtype, and intrathoracic lymph node location.Started on R-CHOP chemotherapy regimen. Responded well to treatment with a reduction in mediastinal mass size and improvement in symptoms.Patient discharged in stable condition with outpatient follow-up for continuation of chemotherapy and monitoring of treatment response.56MaleCaucasian"
    },
    "2268": {
        "explanation_text": "Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of intermittent night sweats and unintentional weight loss over the past 3 months. No other significant medical history reported.The patient presents with fatigue, night sweats, and weight loss.CT scan of the chest and abdomen revealed mediastinal lymphadenopathy with multiple enlarged lymph nodes in the neck, axilla, and groin. Biopsy of the mediastinal lymph node confirmed the diagnosis of Mediastinal (thymic) large B-cell lymphoma.Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites. Verbatim EHR quote justifying the code: 'Biopsy of the mediastinal lymph node confirmed the diagnosis of Mediastinal (thymic) large B-cell lymphoma.'The patient presented with B symptoms and significant lymphadenopathy involving multiple sites. Pathology results indicated large B-cell lymphoma primarily involving the mediastinum with spread to various lymph nodes.The patient has been started on R-CHOP chemotherapy regimen and will undergo regular follow-ups for response assessment.The patient's condition is stable post-diagnosis and treatment initiation. Discharge instructions include monitoring for chemotherapy-related side effects and scheduling follow-up appointments.56 yearsMaleCaucasian"
    },
    "2269": {
        "explanation_text": "Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites.",
        "symptom_text": "The patient has a history of mild asthma, otherwise unremarkable.The patient presented with a persistent dry cough, dyspnea on exertion, and mild chest discomfort.CT scan revealed a large mediastinal mass with extension to the adjacent lung and liver, along with no other lymphadenopathy or organ involvement.Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites. Verbatim EHR quote justifying the code: 'CT scan revealed a large mediastinal mass with extension to the adjacent lung and liver.'The oncologist confirmed the diagnosis of mediastinal large B-cell lymphoma based on the imaging findings and recommended starting chemotherapy.The patient was started on R-CHOP chemotherapy regimen.The patient responded well to treatment and was discharged home with a follow-up appointment in two weeks.55MaleCaucasian"
    },
    "2270": {
        "explanation_text": "Other specified types of non-Hodgkin lymphoma, unspecified site.",
        "symptom_text": "The patient has a history of intermittent night sweats and unintentional weight loss over the past 6 months. No prior history of lymphoma or other malignancies.Presented with painless swelling of cervical lymph nodes, measuring approximately 3 cm in diameter. No systemic symptoms like fever, fatigue, or pruritus reported.CT scan revealed multiple enlarged lymph nodes in the cervical, axillary, and inguinal regions. Excisional biopsy of a cervical lymph node showed atypical lymphoid cells positive for CD20 and negative for CD3, consistent with non-Hodgkin lymphoma.Other specified types of non-Hodgkin lymphoma, unspecified site - The lymph node biopsy confirmed the presence of atypical lymphoid cells positive for CD20 and negative for CD3, consistent with non-Hodgkin lymphoma. No specific subtype or site was identified, leading to the diagnosis of Other specified types of non-Hodgkin lymphoma, unspecified site.The patient's physical examination was significant for painless cervical lymphadenopathy without hepatosplenomegaly. No B symptoms were noted. The patient is scheduled for further staging workup to determine the extent of the disease.The patient will start chemotherapy with R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) for the treatment of non-Hodgkin lymphoma.58FemaleCaucasian"
    },
    "2271": {
        "explanation_text": "Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of recurrent fevers, night sweats, unintentional weight loss, and generalized pruritus over the past few months.The patient presents with painless swelling of multiple lymph nodes in the neck, axilla, and groin regions. There are no specific skin lesions or rashes noted.Excisional biopsy of a cervical lymph node shows atypical lymphoid cells positive for CD20, CD5, and CD23, supporting a diagnosis of Other specified types of non-Hodgkin lymphoma. Flow cytometry reveals a clonal B-cell population.Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites (C8588): The lymph node biopsy demonstrates atypical lymphoid cells positive for CD20, CD5, and CD23, consistent with a diagnosis of Other specified types of non-Hodgkin lymphoma involving multiple lymph node sites.The patient's physical examination is significant for bilateral cervical, axillary, and inguinal lymphadenopathy without hepatosplenomegaly. No skin lesions or other palpable masses are noted. The patient is scheduled for further staging with a PET-CT scan.The patient will start on R-CHOP chemotherapy regimen for the treatment of non-Hodgkin lymphoma. Supportive care measures will also be initiated to manage symptoms and side effects.58MaleCaucasian"
    },
    "2272": {
        "explanation_text": "Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites.",
        "symptom_text": "The patient has a history of recurrent fevers, night sweats, unintentional weight loss, and fatigue over the past few months.The patient presents with enlarged lymph nodes in the abdomen, along with abdominal pain and early satiety. There are no symptoms suggestive of cutaneous involvement or mediastinal masses.CT scan shows multiple enlarged lymph nodes in the abdomen and spleen. Biopsy results indicate non-Hodgkin lymphoma involving extranodal sites.Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites. Verbatim EHR quote justifying the code: 'Biopsy results confirm the presence of non-Hodgkin lymphoma involving extranodal sites.'The patient's physical examination is significant for hepatosplenomegaly and palpable abdominal masses. No palpable lymphadenopathy in the neck, axilla, or inguinal regions.The patient is scheduled for chemotherapy with R-CHOP regimen.The patient responded well to treatment and is scheduled for follow-up appointments for further management.56FemaleCaucasian"
    },
    "2273": {
        "explanation_text": "Non-Hodgkin lymphoma, unspecified, unspecified site.",
        "symptom_text": "The patient has a history of intermittent night sweats and unexplained weight loss over the past few months. No history of autoimmune diseases or other malignancies.The patient presents with generalized lymphadenopathy, fatigue, and occasional low-grade fever. No specific localized lymphadenopathy or organ-specific symptoms.CT scan shows multiple enlarged lymph nodes in various regions without organ infiltration. Biopsy results indicate a diffuse proliferation of atypical lymphoid cells.Non-Hodgkin lymphoma, unspecified, unspecified site. The diagnosis is based on the presence of generalized lymphadenopathy, atypical lymphoid cell proliferation, and absence of specific organ involvement.The patient's physical examination is significant for bilateral cervical, axillary, and inguinal lymphadenopathy. No hepatosplenomegaly or other organomegaly noted. The patient is scheduled for further staging procedures.The patient is planned for chemotherapy regimen R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) following complete staging.The patient tolerated the treatment well without significant adverse effects and is scheduled for regular follow-up visits for response assessment.58FemaleCaucasian"
    },
    "2274": {
        "explanation_text": "Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck.",
        "symptom_text": "The patient has a history of chronic lymphadenopathy in the head, face, and neck region for the past six months.The patient presented with painless swelling of lymph nodes in the head, face, and neck, along with intermittent fevers and night sweats.Biopsy of the cervical lymph nodes confirmed the presence of atypical lymphoid cells consistent with Non-Hodgkin lymphoma.Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck (C8591): The lymph node biopsy revealed atypical lymphoid cells consistent with Non-Hodgkin lymphoma affecting the head, face, and neck lymph nodes.The patient's physical examination showed multiple enlarged, discrete, non-tender lymph nodes in the cervical region. No hepatosplenomegaly or other palpable lymphadenopathy was noted.The patient has been started on chemotherapy regimen R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) for Non-Hodgkin lymphoma.The patient responded well to the initial cycle of chemotherapy and is scheduled for follow-up in two weeks for the next cycle.58MaleCaucasian"
    },
    "2275": {
        "explanation_text": "Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites.",
        "symptom_text": "The patient has a history of unexplained weight loss over the past few months and intermittent night sweats. No other significant medical history reported.The patient presents with fatigue, generalized lymphadenopathy involving multiple sites, and occasional pruritus. No symptoms specific to other lymphoma subtypes are noted.CT scans reveal multiple enlarged lymph nodes in the cervical, axillary, and inguinal regions. Biopsy results demonstrate atypical lymphoid cells consistent with Non-Hodgkin lymphoma, unspecified subtype, involving multiple lymph nodes.Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites. The diagnosis is supported by CT findings of multiple enlarged lymph nodes in various regions and biopsy showing atypical lymphoid cells without specifying a particular subtype.The patient's physical examination is significant for bilateral cervical, axillary, and inguinal lymphadenopathy. No hepatosplenomegaly or other abnormal findings noted. The patient is scheduled for further staging workup to determine the extent of the disease.The patient is planned for chemotherapy regimen R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) to start promptly after staging procedures.56MaleCaucasian"
    },
    "2276": {
        "explanation_text": "Multiple myeloma not having achieved remission.",
        "symptom_text": "The patient has a history of anemia, bone pain, hypercalcemia, and renal insufficiency, which are common in Multiple myeloma.The patient presents with worsening bone pain, fatigue, recurrent infections, and elevated protein levels in the blood and urine.Laboratory tests show monoclonal gammopathy, elevated beta-2 microglobulin, and abnormal plasma cells in the bone marrow biopsy.Multiple myeloma not having achieved remission. Verbatim EHR quote justifying the code: 'Patient diagnosed with Multiple myeloma showing persistent symptoms and abnormal laboratory findings despite treatment.'The oncologist notes the progression of the disease with worsening renal function and increasing M-protein levels.Initiated on a chemotherapy regimen including bortezomib, lenalidomide, and dexamethasone for disease control.The patient is discharged with close follow-up for chemotherapy cycles and monitoring of renal function and disease progression.64MaleCaucasian"
    },
    "2277": {
        "explanation_text": "Multiple myeloma in relapse.",
        "symptom_text": "The patient has a past medical history of multiple myeloma and has undergone previous chemotherapy treatments.The patient presents with bone pain, fatigue, recurrent infections, and renal insufficiency.Laboratory tests show elevated serum M-protein levels, Bence Jones protein in urine, anemia, hypercalcemia, and lytic bone lesions on imaging studies.Multiple myeloma in relapse.The patient's bone marrow biopsy confirms the presence of more than 10% clonal plasma cells, consistent with a relapse of multiple myeloma.The patient is started on a combination chemotherapy regimen with bortezomib, lenalidomide, and dexamethasone.The patient responded well to treatment and is being discharged with close follow-up for disease monitoring and further chemotherapy cycles.64FemaleCaucasian"
    },
    "2278": {
        "explanation_text": "Plasma cell leukemia not having achieved remission.",
        "symptom_text": "The patient has a history of recently diagnosed Plasma cell leukemia and has undergone initial chemotherapy treatment.The patient presents with fatigue, anemia, bone pain, and recurrent infections.Laboratory tests show elevated plasma cells in the bone marrow biopsy and abnormal immunoglobulin levels.Plasma cell leukemia not having achieved remission. The diagnosis is based on the presence of more than 20% plasma cells in the bone marrow and abnormal immunoglobulin levels.The patient is responding well to the current chemotherapy regimen but has not achieved remission yet. Close monitoring of the disease progression is recommended.The patient is receiving chemotherapy with a combination of bortezomib, lenalidomide, and dexamethasone.The patient is stable and will continue outpatient chemotherapy for further management of Plasma cell leukemia.58FemaleCaucasian"
    },
    "2279": {
        "explanation_text": "Solitary plasmacytoma not having achieved remission.",
        "symptom_text": "The patient has a history of chronic back pain for the past six months, which has been gradually worsening.The patient reports localized bone pain in the thoracic spine area, especially with movement. No other constitutional symptoms such as fever, weight loss, or night sweats are present.MRI of the thoracic spine shows a solitary lytic lesion at T7. Bone marrow biopsy reveals a monoclonal plasma cell population of less than 10%.Solitary plasmacytoma not having achieved remission. The patient presents with a solitary lytic lesion on imaging and less than 10% monoclonal plasma cells on bone marrow biopsy, consistent with a diagnosis of solitary plasmacytoma.The patient's presentation is typical for solitary plasmacytoma, with a localized lytic lesion and absence of systemic symptoms or end-organ damage. Treatment options and prognosis discussed with the patient.The patient is scheduled for localized radiation therapy to the thoracic spine lesion.The patient tolerated the radiation therapy well and is scheduled for follow-up appointments to monitor response to treatment.58MaleCaucasian"
    },
    "2280": {
        "explanation_text": "Acute lymphoblastic leukemia not having achieved remission.",
        "symptom_text": "The patient has no relevant past medical history.The patient presents with fatigue, pallor, easy bruising, and recurrent infections.Laboratory tests show leukocytosis, anemia, thrombocytopenia, and presence of lymphoblasts on peripheral blood smear. Bone marrow biopsy confirms the diagnosis of acute lymphoblastic leukemia.Acute lymphoblastic leukemia not having achieved remission. The patient presents with fatigue, pallor, easy bruising, and recurrent infections. Laboratory tests show leukocytosis, anemia, thrombocytopenia, and presence of lymphoblasts on peripheral blood smear. Bone marrow biopsy confirms the diagnosis of acute lymphoblastic leukemia.The patient is a 45-year-old male of Caucasian ethnicity. He has been experiencing worsening fatigue and easy bruising over the past few weeks. On examination, he appears pale, and there are multiple ecchymoses noted on his upper and lower extremities. Laboratory findings reveal leukocytosis, anemia, and thrombocytopenia. Peripheral blood smear shows the presence of lymphoblasts. Bone marrow biopsy confirms the diagnosis of acute lymphoblastic leukemia.The patient has been started on a chemotherapy regimen consisting of vincristine, daunorubicin, prednisone, and intrathecal methotrexate. Supportive care measures including transfusions and antimicrobial prophylaxis have also been initiated.The patient is planned for inpatient chemotherapy cycles with close monitoring for treatment response and side effects. Discharge is pending improvement in blood counts and resolution of infection risks.45MaleCaucasian"
    },
    "2281": {
        "explanation_text": "Acute lymphoblastic leukemia, in remission.",
        "symptom_text": "The patient has a history of acute lymphoblastic leukemia and has undergone chemotherapy leading to the current remission status.The patient is currently asymptomatic with no signs of active leukemia.Recent bone marrow biopsy shows less than 5% blast cells, indicating remission. Immunophenotyping confirms the presence of lymphoblasts with specific markers characteristic of acute lymphoblastic leukemia.Acute lymphoblastic leukemia, in remission. Verbatim EHR quote justifying the code: 'Patient with a history of acute lymphoblastic leukemia, currently in remission following chemotherapy.'Patient is doing well with no complaints. Physical examination reveals no palpable lymph nodes or organomegaly. Blood counts are within normal limits.The patient is being monitored closely in the remission phase with regular follow-up appointments. Chemotherapy was completed successfully.Patient is stable and discharged home with instructions for follow-up visits and monitoring.42FemaleCaucasian"
    },
    "2282": {
        "explanation_text": "Chronic lymphocytic leukemia of B-cell type in remission.",
        "symptom_text": "The patient has a history of Chronic lymphocytic leukemia of B-cell type.The patient is currently asymptomatic with no complaints of fatigue, weight loss, night sweats, or recurrent infections.Recent blood tests show normal complete blood count with no evidence of anemia, thrombocytopenia, or lymphocytosis. Imaging studies reveal no lymphadenopathy or splenomegaly.Chronic lymphocytic leukemia of B-cell type in remission. The patient is currently in remission with no evidence of active disease.The patient reports good tolerance to the previous treatment regimen and is currently under observation for any signs of relapse.The patient is not currently receiving any specific treatment for Chronic lymphocytic leukemia as the disease is in remission. Regular follow-ups and monitoring are scheduled.68MaleCaucasian"
    },
    "2283": {
        "explanation_text": "Chronic lymphocytic leukemia of B-cell type in relapse.",
        "symptom_text": "The patient has a known history of Chronic lymphocytic leukemia of B-cell type and has been undergoing treatment for the past 5 years. The patient has previously responded well to chemotherapy but is now presenting with symptoms suggestive of disease relapse.The patient complains of increasing fatigue, unintentional weight loss, night sweats, and generalized lymphadenopathy. There are no symptoms suggestive of acute leukemia or other types of lymphoma.Peripheral blood smear shows an increased number of abnormal-looking lymphocytes. Flow cytometry confirms the presence of clonal B-cell lymphocytes expressing CD5, CD19, CD20, CD23, and CD200, consistent with a diagnosis of Chronic lymphocytic leukemia. Bone marrow biopsy demonstrates infiltration with small mature lymphocytes.Chronic lymphocytic leukemia of B-cell type in relapse. The diagnosis is supported by the presence of characteristic B-cell markers (CD5, CD19, CD20, CD23, CD200) on flow cytometry and the finding of small mature lymphocytes on bone marrow biopsy.The patient's physical examination is significant for palpable cervical, axillary, and inguinal lymph nodes. There is no hepatosplenomegaly noted. The patient's performance status has declined compared to previous visits.The patient has been started on a salvage chemotherapy regimen including bendamustine and rituximab for the treatment of relapsed Chronic lymphocytic leukemia. Supportive care measures have also been initiated.67MaleCaucasian"
    },
    "2284": {
        "explanation_text": "Acute myeloblastic leukemia, not having achieved remission.",
        "symptom_text": "The patient has no previous history of leukemia or other hematologic disorders.The patient presented with fatigue, unexplained weight loss, and recurrent infections.Bone marrow biopsy revealed greater than 20% myeloblasts with Auer rods. Complete blood count showed pancytopenia with leukocytosis and anemia.Acute myeloblastic leukemia not having achieved remission. The diagnosis is based on the presence of greater than 20% myeloblasts in the bone marrow, Auer rods, and abnormal blood counts consistent with acute myeloblastic leukemia.The patient is being started on induction chemotherapy with cytarabine and daunorubicin.The patient received induction chemotherapy according to the NCCN guidelines for Acute myeloid leukemia.The patient responded well to the initial chemotherapy cycle and will be scheduled for consolidation therapy.58FemaleCaucasian"
    },
    "2285": {
        "explanation_text": "Acute myeloblastic leukemia, in remission.",
        "symptom_text": "The patient has a history of recently diagnosed Acute myeloblastic leukemia.The patient is currently asymptomatic and in remission.Bone marrow biopsy shows less than 5% myeloblasts with no lymphoid markers present, confirming remission status.Acute myeloblastic leukemia, in remission. Verbatim EHR quote justifying the code: 'Acute myeloblastic leukemia, in remission.'Patient is responding well to treatment and currently shows no signs of active disease.Patient is on a maintenance chemotherapy regimen to prevent relapse.Patient is being discharged home with close follow-up for monitoring of remission status.58MaleCaucasian"
    },
    "2286": {
        "explanation_text": "Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission.",
        "symptom_text": "The patient was diagnosed with Chronic myeloid leukemia two years ago and has been on treatment since then.The patient reports fatigue, night sweats, and abdominal fullness.BCR/ABL gene fusion detected on PCR testing.Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission.Patient presents with typical symptoms of Chronic myeloid leukemia and confirmed BCR/ABL positivity. Treatment plan adjusted accordingly.Continuation of tyrosine kinase inhibitor therapy. Close monitoring of blood counts and molecular response.Patient discharged in stable condition with follow-up scheduled in two weeks.45MaleCaucasian"
    },
    "2287": {
        "explanation_text": "Acute promyelocytic leukemia, not having achieved remission.",
        "symptom_text": "The patient has a history of easy bruising, recurrent infections, and fatigue over the past month.Presented with petechiae, ecchymosis, and gingival bleeding. Reports feeling extremely tired and weak. No fever or weight loss reported.Peripheral blood smear shows leukocytosis with a predominance of abnormal promyelocytes. Bone marrow biopsy confirms hypercellularity with a high percentage of promyelocytes. Genetic testing reveals the presence of the t(15;17) translocation.Acute promyelocytic leukemia, not having achieved remission. Verbatim_EHR_quote_justifying_the_code: 'The patient is diagnosed with Acute promyelocytic leukemia based on the presence of abnormal promyelocytes in the peripheral blood and bone marrow, along with the characteristic t(15;17) translocation.'Patient is at high risk of bleeding complications due to severe thrombocytopenia. Start induction chemotherapy with ATRA and arsenic trioxide immediately.Initiated on chemotherapy regimen with ATRA and arsenic trioxide. Supportive care with platelet transfusions and infection prophylaxis.Patient responded well to initial chemotherapy. Discharged with close follow-up for monitoring of blood counts and treatment response.42FemaleCaucasian"
    },
    "2288": {
        "explanation_text": "Other myeloid leukemia not having achieved remission.",
        "symptom_text": "The patient has a history of unexplained fatigue, easy bruising, and recurrent infections over the past few months.The patient presents with fatigue, pallor, petechiae, and splenomegaly.Peripheral blood smear shows increased blasts. Bone marrow biopsy confirms the diagnosis of myeloid leukemia.Other myeloid leukemia not having achieved remission. Verbatim EHR quote justifying the code: 'The bone marrow biopsy revealed a hypercellular marrow with myeloblasts comprising more than 20% of all nucleated cells, consistent with a diagnosis of Other myeloid leukemia.'The patient is being started on induction chemotherapy with a plan for subsequent consolidation and maintenance therapy.Chemotherapy regimen initiated with close monitoring for treatment response and side effects.58FemaleCaucasian"
    },
    "2289": {
        "explanation_text": "Other myeloid leukemia, in remission.",
        "symptom_text": "The patient has a history of myeloid leukemia and has been in remission for the past six months.The patient denies any specific symptoms currently.Recent blood tests show normal white blood cell counts and no blasts in the peripheral blood smear.Other myeloid leukemia, in remissionPatient is doing well with no signs of relapse. Continue regular follow-ups.The patient completed a course of chemotherapy and is currently on maintenance therapy.The patient is stable and discharged home with a follow-up appointment in three months.58FemaleCaucasian"
    },
    "2290": {
        "explanation_text": "Other myeloid leukemia, in relapse.",
        "symptom_text": "The patient has a history of myeloid leukemia and has undergone previous treatments for the condition.The patient presents with fatigue, easy bruising, and recurrent infections.Peripheral blood smear shows increased blasts consistent with myeloid leukemia. Bone marrow biopsy confirms the presence of myeloid blasts.Other myeloid leukemia, in relapse. Verbatim_EHR_quote_justifying_the_code: 'Patient diagnosed with Other myeloid leukemia, in relapse.'Patient is currently experiencing relapse of myeloid leukemia with worsening blood counts.Initiated chemotherapy regimen with cytarabine and daunorubicin for leukemia relapse.Patient responded well to treatment and is scheduled for follow-up appointments for further monitoring.58FemaleCaucasian"
    },
    "2291": {
        "explanation_text": "Chronic myelomonocytic leukemia not having achieved remission.",
        "symptom_text": "The patient has a history of persistent anemia, fatigue, and splenomegaly.The patient presents with fatigue, pallor, and abdominal fullness due to splenomegaly.Lab tests show persistent monocytosis, dysplastic changes in blood cells, and absence of the BCR/ABL fusion gene.Chronic myelomonocytic leukemia not having achieved remission. The bone marrow aspirate shows persistent monocytosis (15% of all nucleated cells) with dysplastic changes in multiple lineages, consistent with the diagnosis of chronic myelomonocytic leukemia.The patient has been undergoing treatment with hypomethylating agents, but despite therapy, there is no evidence of remission based on repeated bone marrow evaluations.The patient is currently receiving supportive care with blood transfusions and monitoring for disease progression.The patient will be scheduled for regular follow-up appointments to monitor response to treatment and disease progression.67FemaleCaucasian"
    },
    "2292": {
        "explanation_text": "Myelodysplastic disease, not elsewhere classified.",
        "symptom_text": "The patient has a history of anemia, thrombocytopenia, and recurrent infections.The patient presents with fatigue, easy bruising, and frequent nosebleeds.Bone marrow biopsy showed dysplastic changes in multiple cell lines without evidence of leukemia.Myelodysplastic disease, not elsewhere classified.The patient's blood work revealed cytopenias with dysplastic changes in the bone marrow, consistent with a diagnosis of Myelodysplastic disease.The patient was started on supportive care with blood transfusions and referred to a hematologist for further management.The patient was discharged in stable condition with close follow-up arranged with the hematologist.67FemaleCaucasian"
    },
    "2293": {
        "explanation_text": "Leukemia, unspecified, in remission.",
        "symptom_text": "The patient has a history of leukemia, unspecified, and has undergone chemotherapy in the past.The patient is currently asymptomatic and has no signs of active leukemia.Recent blood tests show normal complete blood count (CBC) with no abnormal leukocyte levels.Leukemia, unspecified, in remission. Verbatim EHR quote justifying the code: 'Patient diagnosed with Leukemia, unspecified, in remission based on medical history, absence of active symptoms, and normal CBC results.'Patient reports feeling well and is back to routine activities. No palpable lymph nodes or organomegaly on physical examination.No active treatment is indicated at this time as the patient is in remission. Regular follow-ups and monitoring of CBC are recommended.Patient discharged in stable condition. Advised to follow up with oncologist every three months for CBC monitoring and reassessment of leukemia status.58FemaleCaucasian"
    },
    "2294": {
        "explanation_text": "Unifocal Langerhans-cell histiocytosis.",
        "symptom_text": "The patient has no significant past medical history.The patient presented with a solitary bone lesion in the right femur, which was incidentally discovered during a routine X-ray for an unrelated injury. The patient denies any pain, fever, weight loss, or other systemic symptoms.MRI of the right femur revealed a lytic lesion with cortical breakthrough. Biopsy of the lesion showed an infiltration of Langerhans cells with characteristic CD1a and S100 positivity.Unifocal Langerhans-cell histiocytosis (ICD-10-CM code C966): \"Langerhans-cell histiocytosis, unifocal\".The patient's physical examination was unremarkable except for mild tenderness over the right femur. There were no signs of infection or inflammation. The patient's laboratory tests, including complete blood count and inflammatory markers, were within normal limits.The patient was started on local radiation therapy to the right femur lesion. Pain management was achieved with acetaminophen as needed.The patient responded well to treatment with resolution of the bone lesion. The patient was discharged in stable condition with a scheduled follow-up appointment in three months.42FemaleCaucasian"
    },
    "2295": {
        "explanation_text": "Unspecified type of carcinoma in situ of left breast.",
        "symptom_text": "The patient has a history of regular breast screenings due to a family history of breast cancer. No prior history of hematologic disorders or other malignancies.The patient is asymptomatic and denies any breast lumps, nipple discharge, or breast pain.Mammography revealed microcalcifications in the left breast. Core needle biopsy confirmed the presence of carcinoma in situ.Unspecified type of carcinoma in situ of left breast. Verbatim_EHR_quote_justifying_the_code: 'Core needle biopsy of the left breast confirmed the presence of carcinoma in situ.'No palpable masses or axillary lymphadenopathy noted upon physical examination. The patient's left breast shows no signs of inflammation or skin changes.Scheduled for a lumpectomy followed by radiation therapy.N/A52FemaleCaucasian"
    },
    "2296": {
        "explanation_text": "Carcinoma in situ of bladder.",
        "symptom_text": "The patient has a history of smoking for 20 years.The patient presented with painless hematuria.Biopsy results showed abnormal cells confined to the bladder lining.Carcinoma in situ of bladder is characterized by the presence of abnormal cells confined to the bladder lining without invasion into deeper layers. This diagnosis is supported by the biopsy results showing abnormal cells confined to the bladder lining.The patient is scheduled for a cystoscopy to further evaluate the extent of the carcinoma in situ.The patient has been prescribed intravesical immunotherapy.The patient was discharged in stable condition with a follow-up appointment scheduled in two weeks.65MaleCaucasian"
    },
    "2297": {
        "explanation_text": "Benign neoplasm of parotid gland.",
        "symptom_text": "The patient has a history of a slowly growing painless lump in the right parotid region for the past six months.The patient reports no pain, facial weakness, or difficulty in swallowing or speaking. No history of weight loss, fatigue, or night sweats.Fine-needle aspiration biopsy revealed a well-circumscribed mass with benign features consistent with a pleomorphic adenoma.Benign neoplasm of parotid gland (ICD-10-CM code D110): A benign neoplasm of the right parotid gland, confirmed by fine-needle aspiration biopsy.Physical examination shows a mobile, non-tender mass in the right parotid region. No facial nerve involvement or cervical lymphadenopathy noted.Surgical excision of the parotid gland mass is planned with close monitoring for any recurrence.The patient is scheduled for a parotidectomy and will follow up for post-operative care and pathology results.55FemaleCaucasian"
    },
    "2298": {
        "explanation_text": "Benign neoplasm of ascending colon.",
        "symptom_text": "The patient has a history of intermittent constipation and abdominal discomfort over the past six months.The patient presents with mild crampy abdominal pain in the right lower quadrant, occasional rectal bleeding, and unintentional weight loss.Colonoscopy revealed a 2 cm polypoid mass in the ascending colon, confirmed by biopsy as a benign neoplasm.Benign neoplasm of ascending colonThe patient's symptoms and diagnostic tests are consistent with a benign neoplasm located in the ascending colon. No evidence of metastasis or malignant features were noted.The patient is scheduled for a laparoscopic right hemicolectomy for definitive treatment.The patient underwent surgery without complications and was discharged in stable condition. Follow-up colonoscopies are recommended for surveillance.58FemaleCaucasian"
    },
    "2299": {
        "explanation_text": "Benign neoplasm of descending colon.",
        "symptom_text": "No significant medical history of note.The patient reported mild intermittent left lower abdominal pain and occasional changes in bowel habits.Colonoscopy revealed a polypoid mass in the descending colon measuring 2 cm in diameter. Biopsy results confirmed the presence of benign neoplastic cells.Benign neoplasm of descending colon.Patient shows no signs of metastasis or invasion into surrounding tissues. The neoplasm appears well-contained within the descending colon.Scheduled for a laparoscopic left hemicolectomy to remove the benign neoplasm. Post-operative follow-up and surveillance recommended.Patient recovering well post-surgery, advised on dietary modifications and importance of follow-up appointments for surveillance.58FemaleCaucasian"
    }
}